SCN2A explained
Sodium channel protein type 2 subunit alpha, also known as Nav1.2, is an ion channel protein encoded by the SCN2A gene in humans.[1] It represents one member of the sodium channel alpha subunit gene family. The SCN2A gene is located on chromosome 2 (2q24.3) in proximity to two other voltage-gated sodium channel genes, namely SCN1A and SCN9A.[2] Nav1.2 is distributed throughout the human central nervous system where it plays a major role in the initiation and propagation of action potentials. It is absent from peripheral tissues, with the exception of enteric neurons.[3] Pathologic mutations in the SCN2A gene cause a broad spectrum of neurological conditions, such as epilepsy, autism spectrum disorder (ASD), intellectual disability (ID) and/or developmental delay, called SCN2A-related disorders.[4]
Structure
The SCN2A gene is composed of 27 exons and comprises more than 150 kilobases. There are two major splice variants known, a neonatal isoform and an adult isoform, which differ in one amino acid at position 209 (Asn versus Asp). The neonatal isoform might limit neuronal excitability during development. The voltage-gated sodium channel Nav1.2 encoded by the SCN2A gene consists of 2005 amino acids. This single polypeptide forms a pseudotetrameric channel of four similar domains (I - IV) where each domain contains 6 transmembrane segments, including a voltage sensing region, a pore forming region and an ion-selectivity filter.[5] In the living organism, Nav1.2 is a transmembrane glycoprotein complex composed of a large alpha subunit (encoded by the SCN2A gene) and one or more regulatory beta subunits (encoded by SCNxB genes).[6]
Function
The principal function of Nav1.2, similar to other members of the voltage-gated sodium channel family, is to mediate sodium influx into neurons upon membrane depolarization, thereby generating and propagating action potentials across distinct neuronal subtypes.
Nav1.2 functions mainly in excitatory neurons in cortical structures similar to Nav1.6, whereas expression of Nav1.1 (encoded by the SCN1A gene) is found in mutual distinct, inhibitory neuronal classes.[7] However, the distribution of Nav1.2 changes during development. Nav1.2 channels are initially expressed at the axon initial segments (the site of action potential initiation) of excitatory pyramidal cells in both hippocampal and cortical excitatory cells. While these levels remain constant in the hippocampus, in cortical excitatory cells, Nav1.2 becomes restricted to the portion of the axon initial segment closest to the cell body and in dendrites at the age of 1–2 years in humans. Nav1.6 gradually becomes the predominant channel type at the distal axon initial segment and axonal nodes of Ranvier. In mature neurons, Nav1.2 is distributed only throughout unmyelinated axons. In contrast, its expression pattern in the cerebellum seems to persist throughout development, suggesting distinct roles for Nav1.2 in mature neurons of the neocortex and cerebellum. When Nav1.6 takes over the initiation of action potentials, Nav1.2 might play a crucial role in driving their backpropagation into dendrites. This backpropagation could impact activity-dependent processes such as synaptic maturation, plasticity, and gene transcription.
The activity of Nav1.2 is influenced by several factors, such as protein-protein interactions, posttranslational modifications (e.g. phosphorylation, pamitoylation), and changes in intracellular Ca2+ concentration.
Clinical significance
Mutations in the SCN2A gene can cause a broad spectrum of disorders collectively referred to as SCN2A-related disorders. These include cases of ASD, self-limited epilepsy, early infantile developmental and epileptic encephalopathy, later onset developmental and epileptic encephalopathy, infantile spasms, SCN2A-related disorders without epilepsy, episodic ataxia, and further movement disorders. Two major groups of SCN2A mutations can be distinguished based on their functional consequences and response to seizure medication: gain of function mutations, typically associated with seizure onset within the first three months of life, and loss of function mutations, in which seizures begin after the first three months or may never occur. The former group tends to benefit from treatment with sodium channel blockers, whereas in the latter, such treatment is often ineffective or may even exacerbate seizures.[8] Notably, SCN2A is known to be the most prominent genetic risk factor for autism-spectrum-disorders.
SCN2A gene mutations have also been identified in bitemporal glucose hypometabolism,[9] and bipolar disorder.[10] Furthermore, mutations in SCN2A have been demonstrated to impair enteric neuron migration during development, which may result in gastrointestinal dysmotility, consistent with gastric motility symptoms reported in ASD patients with underlying SCN2A mutations.
See also
Further reading
- Catterall WA, Goldin AL, Waxman SG . International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels . Pharmacological Reviews . 57 . 4 . 397–409 . December 2005 . 16382098 . 10.1124/pr.57.4.4 . 7332624 .
- Lu CM, Han J, Rado TA, Brown GB . Differential expression of two sodium channel subtypes in human brain . FEBS Letters . 303 . 1 . 53–58 . May 1992 . 1317301 . 10.1016/0014-5793(92)80476-W . 29330026 . 1992FEBSL.303...53L .
- Ahmed CM, Ware DH, Lee SC, Patten CD, Ferrer-Montiel AV, Schinder AF, McPherson JD, Wagner-McPherson CB, Wasmuth JJ, Evans GA . Primary structure, chromosomal localization, and functional expression of a voltage-gated sodium channel from human brain . Proceedings of the National Academy of Sciences of the United States of America . 89 . 17 . 8220–8224 . September 1992 . 1325650 . 49889 . 10.1073/pnas.89.17.8220 . free . 1992PNAS...89.8220A .
- Han JA, Lu CM, Brown GB, Rado TA . Direct amplification of a single dissected chromosomal segment by polymerase chain reaction: a human brain sodium channel gene is on chromosome 2q22-q23 . Proceedings of the National Academy of Sciences of the United States of America . 88 . 2 . 335–339 . January 1991 . 1846440 . 50805 . 10.1073/pnas.88.2.335 . free . 1991PNAS...88..335H .
- Litt M, Luty J, Kwak M, Allen L, Magenis RE, Mandel G . Localization of a human brain sodium channel gene (SCN2A) to chromosome 2 . Genomics . 5 . 2 . 204–208 . August 1989 . 2571571 . 10.1016/0888-7543(89)90047-5 .
- Bonaldo MF, Lennon G, Soares MB . Normalization and subtraction: two approaches to facilitate gene discovery . Genome Research . 6 . 9 . 791–806 . September 1996 . 8889548 . 10.1101/gr.6.9.791 . free .
- Lu CM, Eichelberger JS, Beckman ML, Schade SD, Brown GB . Isolation of the 5'-flanking region for human brain sodium channel subtype II alpha-subunit . Journal of Molecular Neuroscience . 11 . 3 . 179–182 . December 1998 . 10344788 . 10.1385/JMN:11:3:179 . 33328638 .
- Baulac S, Gourfinkel-An I, Picard F, Rosenberg-Bourgin M, Prud'homme JF, Baulac M, Brice A, LeGuern E . A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33 . American Journal of Human Genetics . 65 . 4 . 1078–1085 . October 1999 . 10486327 . 1288241 . 10.1086/302593 .
- Schade SD, Brown GB . Identifying the promoter region of the human brain sodium channel subtype II gene (SCN2A) . Brain Research. Molecular Brain Research . 81 . 1–2 . 187–190 . September 2000 . 11000491 . 10.1016/S0169-328X(00)00145-5 .
- Kasai N, Fukushima K, Ueki Y, Prasad S, Nosakowski J, Sugata K, Sugata A, Nishizaki K, Meyer NC, Smith RJ . Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus . Gene . 264 . 1 . 113–122 . February 2001 . 11245985 . 10.1016/S0378-1119(00)00594-1 .
- Malacarne M, Gennaro E, Madia F, Pozzi S, Vacca D, Barone B, dalla Bernardina B, Bianchi A, Bonanni P, De Marco P, Gambardella A, Giordano L, Lispi ML, Romeo A, Santorum E, Vanadia F, Vecchi M, Veggiotti P, Vigevano F, Viri F, Bricarelli FD, Zara F . Benign familial infantile convulsions: mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity . American Journal of Human Genetics . 68 . 6 . 1521–1526 . June 2001 . 11326335 . 1226140 . 10.1086/320596 .
- Sugawara T, Tsurubuchi Y, Agarwala KL, Ito M, Fukuma G, Mazaki-Miyazaki E, Nagafuji H, Noda M, Imoto K, Wada K, Mitsudome A, Kaneko S, Montal M, Nagata K, Hirose S, Yamakawa K . A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction . Proceedings of the National Academy of Sciences of the United States of America . 98 . 11 . 6384–6389 . May 2001 . 11371648 . 33477 . 10.1073/pnas.111065098 . free . 2001PNAS...98.6384S .
- Heron SE, Crossland KM, Andermann E, Phillips HA, Hall AJ, Bleasel A, Shevell M, Mercho S, Seni MH, Guiot MC, Mulley JC, Berkovic SF, Scheffer IE . Sodium-channel defects in benign familial neonatal-infantile seizures . Lancet . 360 . 9336 . 851–852 . September 2002 . 12243921 . 10.1016/S0140-6736(02)09968-3 . 6105850 .
- Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, Reichert J, Buxbaum JD, Meisler MH . Sodium channels SCN1A, SCN2A and SCN3A in familial autism . Molecular Psychiatry . 8 . 2 . 186–194 . February 2003 . 12610651 . 10.1038/sj.mp.4001241 . 16606651 .
- Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, Ferriera H, Lilly J, DiStefano PS, Catterall WA, Scheuer T, Curtis R . Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2 . The Journal of Neuroscience . 23 . 20 . 7577–7585 . August 2003 . 12930796 . 6740763 . 10.1523/JNEUROSCI.23-20-07577.2003 .
- McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL . Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin . The Journal of Biological Chemistry . 279 . 16 . 16044–16049 . April 2004 . 14761957 . 10.1074/jbc.M400856200 . free .
- Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, Makita N, Tanaka M, Fukushima K, Fujiwara T, Inoue Y, Yamakawa K . A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline . The Journal of Neuroscience . 24 . 11 . 2690–2698 . March 2004 . 15028761 . 6729532 . 10.1523/JNEUROSCI.3089-03.2004 .
- Berkovic SF, Heron SE, Giordano L, Marini C, Guerrini R, Kaplan RE, Gambardella A, Steinlein OK, Grinton BE, Dean JT, Bordo L, Hodgson BL, Yamamoto T, Mulley JC, Zara F, Scheffer IE . Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy . Annals of Neurology . 55 . 4 . 550–557 . April 2004 . 15048894 . 10.1002/ana.20029 . 11604421 .
- Pereira S, Vieira JP, Barroca F, Roll P, Carvalhas R, Cau P, Sequeira S, Genton P, Szepetowski P . Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A . Neurology . 63 . 1 . 191–192 . July 2004 . 15249644 . 10.1212/01.wnl.0000132844.20654.c1 . 38453487 .
External links
Patient advocacy organizations (PAO / PAG)
Other links
Notes and References
- Web site: Entrez Gene: SCN2A sodium channel, voltage-gated, type II, alpha subunit .
- Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW . De novo mutations revealed by whole-exome sequencing are strongly associated with autism . Nature . 485 . 7397 . 237–241 . April 2012 . 22495306 . 3667984 . 10.1038/nature10945 . 2012Natur.485..237S .
- Web site: McCluskey . Kate E. . Stovell . Katherine M. . Law . Karen . Kostyanovskaya . Elina . Schmidt . James . Exner . Cameron R. T. . Dea . Jeanselle . Brimble . Elise . State . Matthew W. . 2024-05-29 . Autism gene variants disrupt enteric neuron migration and cause gastrointestinal dysmotility . 2026-02-15 . doi.org.
- Book: George Jr AL . Abbott M, Bender KJ, Brunklaus A, Demarest S, Egan S, Haviland I, Kearney JA, Myers LS, Olson HE, Sanders SJ . SCN2A-related disorders . Cambridge, United Kingdom New York, NY . 2024 . Cambridge University Press . 978-1-009-53036-1 . Cambridge elements. Elements in genetics in epilepsy .
- de Lera Ruiz M, Kraus RL . Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications . Journal of Medicinal Chemistry . 58 . 18 . 7093–7118 . September 2015 . 25927480 . 10.1021/jm501981g .
- Leterrier C, Brachet A, Fache MP, Dargent B . Voltage-gated sodium channel organization in neurons: protein interactions and trafficking pathways . Neuroscience Letters . 486 . 2 . 92–100 . December 2010 . 20817077 . 10.1016/j.neulet.2010.08.079 . Proteomics of Voltage-Gated Ion Channels .
- Catterall WA, Kalume F, Oakley JC . NaV1.1 channels and epilepsy . The Journal of Physiology . 588 . Pt 11 . 1849–1859 . June 2010 . 20194124 . 2901973 . 10.1113/jphysiol.2010.187484 .
- Wolff M, Johannesen KM, Hedrich UB, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, Õiglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, Møller RS . Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders . Brain . 140 . 5 . 1316–1336 . May 2017 . 28379373 . 10.1093/brain/awx054 . free . 1765/100043 .
- Sundaram SK, Chugani HT, Tiwari VN, Huq AH . SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism . Pediatric Neurology . 49 . 1 . 46–49 . July 2013 . 23827426 . 3868437 . 10.1016/j.pediatrneurol.2013.03.002 .
- Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JR, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JM, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LM, Ori AP, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DH, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P . Genome-wide association study identifies 30 loci associated with bipolar disorder . Nature Genetics . 51 . 5 . 793–803 . May 2019 . 31043756 . 6956732 . 10.1038/s41588-019-0397-8 .
- Web site: ICD-10-CM/PCS MS-DRG v43.0 Definitions Manual . October 15, 2025 . Centers for Medicaid and Medicare Services .